PubMed COVID-19 Clinical Care

Prepositioning relief network is an effective strategy to mitigate the impact of natural disasters and public health emergencies, such as the COVID-19 pandemic. However, designing a proper network is challenging due to limited information and, more

CONCLUSIONS: After 12 months, persistent symptoms were declared by 65.7% of patients. The most common symptoms 3 and 12 months after infection are worse tolerance to exercise, fatigue, palpitations, and memory or concentration problems. Females are

CONCLUSIONS: COVID-19 prognosis improved over time in patients with rheumatic diseases, especially in the Omicron BA.5-dominant period. In the future, treatment of mild cases should be optimised.

Wildlife can be a reservoir and source of zoonotic pathogens for humans. For instance, pangolins were considered one of the potential animal reservoirs of SARS-CoV-2. The aim of this study was to assess the prevalence of antimicrobial-resistant

CONCLUSION: Further research is needed to advance risk management strategies and protect resources within health promotion. System shocks such as bushfires and COVID-19 are inevitable, and despite multiple adaptation opportunities, this intervention

No abstract

BACKGROUND: Severe COVID-19 is associated with innate immunopathology, and CD14, a proximal activator of innate immunity, has been suggested as a potential therapeutic target.

The COVID-19 pandemic focused attention on long-term care facilities' need for infection-control policies that balanced community safety and individual well-being. Infection-control policies were often developed, implemented, and mandated without the

CONCLUSION: Patients with more severe PDR and greater delay in appointments due to the COVID-19 pandemic were more likely to require vitrectomy for proliferative complications. Patient-directed rescheduling was identified as the main driver of care

Autologous hematopoietic stem cell transplantation (HSCT) for relapsed Hodgkin's lymphoma increases the risk of infection by using intensive chemotherapy. This risk is obviously ongoing given the increased virulence of severe COVID-19. We report a